pembrolizumab,pds0101
pds biotech,merck
['pds0101', 'keytruda', '$hook', '$pdsb']
1l combination with keytruda,
$hook hb-200 vs $pdsb pds0101 (per #asco23 pds0101 poster): 43% orr (6/14 patients with confirmed responses) vs 27.3% (9/33 patients with confirmed responses); note: 19% orr and 47% drc for keytruda 1l alone. 
Engineering background. 25+ yrs in the stock market. Early retired to trade full-time. Value-driven & CANSLIM. Inspired by Mark Minervini et al. Posts ≠ Advice.